The effect of 2,3-diphosphoglycerate on the solubility of deoxyhemoglobin S
- PMID: 3753004
- DOI: 10.1016/0003-9861(86)90006-8
The effect of 2,3-diphosphoglycerate on the solubility of deoxyhemoglobin S
Abstract
Although highly charged polyanions, such as inositol hexaphosphate, have been clearly shown to decrease the solubility of deoxyhemoglobin S, the effect of 2,3-diphosphoglycerate (DPG), the endogenous allosteric effector within the red cell, has been more controversial. In this work we have compared the effect of DPG on the solubility of native deoxyhemoglobin S and a derivative in which the DPG binding site is blocked by cross-linking the two beta 82 lysine residues. At pH 6.6 and 30 degrees C the solubility of deoxyhemoglobin S was found to be decreased by 15% (i.e., from 18.8 to 16.0 g/dl) in the presence of saturating concentrations of DPG. Under the same conditions DPG had no effect on the solubility of the cross-linked derivative. This result establishes unequivocally that the binding of DPG within the beta cleft directly facilitates the polymerization of deoxyhemoglobin S. Under physiological conditions, the solubility of deoxyhemoglobin S was found to be decreased by 6% in the presence of an equimolar concentration of DPG. A solubility decrease of this magnitude is sufficient to enhance the tendency of SS cells to sickle and may exacerbate the clinical symptoms of sickle cell disease.
Similar articles
-
Deoxygenated sickle hemoglobin. Modulation of its solubility by 2,3-diphosphoglycerate and other allosteric polyanions.J Biol Chem. 1985 Nov 15;260(26):13897-900. J Biol Chem. 1985. PMID: 4055763
-
2,3-Diphosphoglycerate and intracellular pH as interdependent determinants of the physiologic solubility of deoxyhemoglobin S.Blood. 1990 Sep 1;76(5):1028-36. Blood. 1990. PMID: 2393711
-
Effect of 2, 3-diphosphoglycerate on the solubility of deoxy-sickle hemoglobin.Hemoglobin. 1977;1(6):527-37. doi: 10.3109/03630267709003417. Hemoglobin. 1977. PMID: 914634
-
Structural features required for the reactivity and intracellular transport of bis(3,5-dibromosalicyl)fumarate and related anti-sickling compounds that modify hemoglobin S at the 2,3-diphosphoglycerate binding site.J Biol Chem. 1984 Dec 10;259(23):14863-73. J Biol Chem. 1984. PMID: 6501320
-
Antisickling effects of 2,3-diphosphoglycerate depletion.Blood. 1995 Jun 1;85(11):3289-96. Blood. 1995. PMID: 7756662
Cited by
-
VZHE-039, a novel antisickling agent that prevents erythrocyte sickling under both hypoxic and anoxic conditions.Sci Rep. 2020 Nov 20;10(1):20277. doi: 10.1038/s41598-020-77171-2. Sci Rep. 2020. PMID: 33219275 Free PMC article.
-
Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.Hematol Oncol Clin North Am. 2014 Apr;28(2):217-31. doi: 10.1016/j.hoc.2013.11.001. Epub 2014 Jan 21. Hematol Oncol Clin North Am. 2014. PMID: 24589263 Free PMC article. Review.
-
Adenosine signaling in normal and sickle erythrocytes and beyond.Microbes Infect. 2012 Aug;14(10):863-73. doi: 10.1016/j.micinf.2012.05.005. Epub 2012 May 23. Microbes Infect. 2012. PMID: 22634345 Free PMC article. Review.
-
Detrimental effects of adenosine signaling in sickle cell disease.Nat Med. 2011 Jan;17(1):79-86. doi: 10.1038/nm.2280. Epub 2010 Dec 19. Nat Med. 2011. PMID: 21170046 Free PMC article.
-
Rational modification of vanillin derivatives to stereospecifically destabilize sickle hemoglobin polymer formation.Acta Crystallogr D Struct Biol. 2018 Oct 1;74(Pt 10):956-964. doi: 10.1107/S2059798318009919. Epub 2018 Oct 2. Acta Crystallogr D Struct Biol. 2018. PMID: 30289405 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources